Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals
(KNSA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Arcalyst
Rilonacept
2008-02-27
Inborn genetic diseases
,
Inflammation
,
Cryopyrin-associated periodic syndromes
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Rilonacept
diabetes mellitus
,
type 1 diabetes mellitus
,
hearing loss
,
deafness
,
brucellosis
,
kidney diseases
,
juvenile arthritis
,
adult-onset still's disease
,
alcoholic hepatitis
,
cardiovascular diseases
,
systemic scleroderma
,
localized scleroderma
,
diffuse scleroderma
,
sclerosis
,
eosinophilia
,
cellulitis
,
schnitzler syndrome
,
anemia
,
coronary artery disease
,
atherosclerosis
,
sarcoidosis
,
arthritis
,
gout
,
inborn genetic diseases
,
familial mediterranean fever
,
metabolic diseases
,
rheumatic diseases
,
joint diseases
,
musculoskeletal diseases
,
inborn errors metabolism
,
inborn errors purine-pyrimidine metabolism
,
fever
,
syndrome
,
hereditary autoinflammatory diseases
,
amyloidosis
,
hyperthermia
,
urticaria
,
cold urticaria
,
recurrence
,
pericarditis
,
cryopyrin-associated periodic syndromes
,
inflammation
,
chronic renal insufficiency
Mavrilimumab
healthy volunteers/patients
,
rheumatoid arthritis
,
arthritis
,
respiratory insufficiency
,
severe acute respiratory syndrome-related coronavirus
,
sars-cov-2
,
necrosis
,
respiratory distress syndrome
,
viral pneumonia
,
giant cell arteritis
,
covid-19
,
pneumonia
,
inflammation
Cilmostim
glioblastoma
Regramostim
brain neoplasms
,
neoplasms
,
glioblastoma
,
neuroblastoma
,
glioma
,
osteosarcoma
,
medulloblastoma
,
rhabdoid tumor
,
ependymoma
,
ewing sarcoma
,
rhabdomyosarcoma
,
diffuse intrinsic pontine glioma
,
leukemia
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
congenital abnormalities
,
megakaryoblastic leukemia acute
,
monocytic leukemia acute
,
myelomonocytic leukemia acute
,
refractory anemia with excess of blasts
,
erythroblastic leukemia acute
Molgramostim
glioblastoma
Bevifimod
adenocarcinoma
,
prostatic neoplasms
VIXARELIMAB
pruritus
,
neurodermatitis
,
ulcerative colitis
,
psoriasis
,
lichen planus
,
chronic urticaria
,
urticaria
,
prurigo
,
systemic scleroderma
,
idiopathic pulmonary fibrosis
,
colitis
,
ulcer
Globulin, immune
lymphoma
Bos taurus adrenal cortex corticosteroids
myelodysplastic syndromes
,
myeloid leukemia acute
,
recurrence
,
precursor cell lymphoblastic leukemia-lymphoma
,
neoplasm metastasis
,
biphenotypic leukemia acute
,
polymyalgia rheumatica
,
t-cell lymphoma
,
precursor t-cell lymphoblastic leukemia-lymphoma
,
ovarian neoplasms
,
atopic dermatitis
,
ulcerative colitis
,
covid-19
,
arteritis
,
takayasu arteritis
,
aortic arch syndromes
,
giant cell arteritis
,
crohn disease
,
eczema
,
dermatitis
,
panuveitis
,
colitis
,
ulcer
Sagramostim
inflammation
,
blister
,
rheumatoid arthritis
,
arthritis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use